Literature DB >> 23461724

Analysis of MEF2A mutations in a Chinese population with premature coronary artery disease.

Yuxiang Dai1, Shuyang Zhang, Wei Wu.   

Abstract

AIMS: To assess the relationship between mutations of the myocyte enhancer factor 2A (MEF2A) and premature coronary artery disease (PCAD) in a Chinese population. METHODS AND
RESULTS: The mutations in the exons 8 and 12 of the MEF2A gene were analyzed in both PCAD families and sporadic cases using direct sequencing of polymerase chain reaction products. In one PCAD family, seven members of the third generation were all diagnosed with CAD, and five of them had PCAD. All five members with PCAD displayed a mutation of the TT genotype in the site of 1353 G/T. Moreover, three of them (3/5) had a mutation of the DW genotype in the site of 1291-1293 CCG W/D. In sporadic cases, we also found that the haplotype of 1291-1293 CCG D+1305 G+1353 T was significantly associated with PCAD.
CONCLUSIONS: The mutations of MEF2A exon 12 are implicated in PCAD, suggesting a strong genetic component in the pathogenesis of PCAD in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23461724     DOI: 10.1089/gtmb.2012.0467

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  2 in total

1.  Myocyte Enhancer Factor-2A Gene Mutation and Coronary Artery Disease.

Authors:  Ying Jiang; Hong-Bin Liu
Journal:  Chin Med J (Engl)       Date:  2015-10-05       Impact factor: 2.628

2.  MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.

Authors:  Benrong Liu; Lihua Pang; Yang Ji; Lei Fang; Chao Wei Tian; Jing Chen; Changnong Chen; Yun Zhong; Wen-Chao Ou; Yujuan Xiong; Shi Ming Liu
Journal:  Front Cardiovasc Med       Date:  2022-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.